Alkermes
anti tumor activity in melanoma | Alkermes
Company
Deck Type
Sector
Industry
Deck date
June 2021
Slide
13 of 31
Similar slides by Alkermes
See diffirences between slides (animation)
Results
June 2021
anti tumor activity in renal cell carcinoma | Alkermes
Related slides by other companies
Fusion Pharmaceuticals
IPO
June 2020
compelling anti tumor activity across multiple tumor models and tumor sizes i with a single dose with alphas using the right | Fusion Pharmaceuticals
Kymera
Investor Presentation
August 2023
objectives a a | Kymera
BioAtla
Investor Presentation
August 2022
phase results with support advancing into phase | BioAtla
BioAtla
Investor Presentation
August 2023
phase results with support advancing into phase | BioAtla
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights